Vy Spine Achieves FDA Clearance for Innovative Lumbar Device
Vy Spine Receives FDA Clearance for Advanced Spinal Device
Vy Spine, known for its groundbreaking advancements in spinal technology, has recently achieved a significant milestone with the clearance from the U.S. Food and Drug Administration (FDA) for its LumiVy OsteoVy PEKK Lumbar Interbody Fusion (IBF) device. This cutting-edge implant is set to revolutionize treatments for patients with degenerative disc disease.
Understanding the LumiVy OsteoVy PEKK Lumbar IBF
The LumiVy OsteoVy PEKK Lumbar IBF is designed specifically for intervertebral body fusion. It can be utilized at one or two contiguous levels in the lumbar spine, catering to conditions such as Grade 1 spondylolisthesis and degenerative disc disease. This innovative device is crafted from OXPEKK, a material recognized for its osseointegration properties, which is further enhanced by the unique OsteoVy lattice structure exclusive to Vy Spine.
Key Features of the Device
One of the standout features of the LumiVy OsteoVy PEKK Lumbar IBF is its versatility in implantation. It is available in various footprints and heights, ranging from 6mm to 21mm to accommodate multiple lumbar interbody approaches. These include anterior, oblique anterior, lateral, oblique posterior, posterior, and transforaminal techniques. The device also offers options in lordosis, which contributes to its adaptability in different surgical scenarios.
Benefits of OXPEKK Material
OXPEKK is not just a high-performance polymer; it has exhibited remarkable benefits in clinical settings. It has shown significant bone ingrowth, minimal radiographic interference, and resistance to fibrotic tissue formation. Additionally, it boasts a higher push-out strength compared to standard PEEK materials. Notably, OXPEKK is bacterostatic, making it an excellent choice for patients who may have sensitivities to metal implants.
Expert Perspectives on the Product Launch
Bret Berry, the President of Product Development at Vy Spine, expressed enthusiasm about the clearance, stating, “The LumiVy OsteoVy PEKK Lumbar IBF clearance is another addition to our line of innovative implants, showcasing the distinctive qualities of our proprietary designs.” He emphasized that through thorough research, Vy Spine has identified the unique advantages of OXPEKK over traditional materials like PEEK, setting a new standard in spinal health solutions.
Scott DeFelice, CEO of Oxford Performance Materials, shared his excitement as well, saying, “This milestone with our second OsteoFab product approval reflects our commitment to innovation. The combination of OPM’s advanced 3D printed PEKK technology and Vy Spine’s unique design capabilities positions us for significant market growth.”
About Vy Spine and Its Mission
Founded with the vision of advancing spinal care, Vy Spine has made great strides by combining tried-and-tested technologies with innovative materials. Their strategy is rooted in collaboration with leading spine innovators, enabling them to provide cost-effective yet sophisticated solutions tailored to spine care needs. Their approach consistently keeps patient health and safety at the forefront of their innovations.
The Impact of Advanced Materials in Orthopedic Devices
Oxford Performance Materials (OPM) is a notable player in the materials engineering world, specialized in developing and marketing cutting-edge additive manufacturing technologies. Their OsteoFab technology is particularly notable, as it leverages the capabilities of PEKK polymers to produce diverse orthopedic devices designed to tackle current challenges in the industry comprehensively. With a range of applications including trauma, oncology, and spinal devices, OPM continues to lead with innovations that prioritize not just function, but overall patient well-being.
Frequently Asked Questions
What is the LumiVy OsteoVy PEKK Lumbar IBF?
The LumiVy OsteoVy PEKK Lumbar IBF is an innovative interbody fusion device designed for lumbar spine surgeries, particularly effective for treating degenerative disc disease.
What makes OXPEKK different from traditional materials?
OXPEKK offers superior properties like enhanced osseointegration, no formation of fibrotic membranes, and significant push-out strength compared to standard PEEK.
How does the LumiVy device support spinal fusion?
The device facilitates spinal fusion by providing a stable environment conducive to bone growth, enhancing recovery and treatment outcomes for patients.
Who can benefit from using the LumiVy OsteoVy PEKK Lumbar IBF?
Patients suffering from conditions like degenerative disc disease and moderate spondylolisthesis are prime candidates for this advanced interbody fusion device.
What is Vy Spine's approach to spinal care?
Vy Spine focuses on innovation, collaboration, and the use of advanced materials to provide effective and safe spine care solutions while striving to stay ahead in technology.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Newmark Group Unveils Financial Performance Plans for Q3 2024
- Investment Insight: 3 Promising Stocks for Future Gains
- Transforming $1000 into Nearly $7000: Coherent's Stellar Journey
- Jessie Murph to Headline Unique Concert for Voter Engagement
- STAG Industrial Maintains Monthly Dividend for Fourth Quarter
- Central Securities Achieves Remarkable Milestone in Stock Growth
- Helen of Troy's Financial Performance: Challenges Ahead
- LEVY Health Secures Funds to Revolutionize Reproductive Care
- Challenges for Cyclacel Pharmaceuticals Amid Stock Drop
- Argan Inc. Achieves Major Growth with Stock Surge to $112.8
Recent Articles
- Roblox Challenges Hindenburg Claims About Metrics and Safety Protocols
- Celebrating the Essential Role of Pharmacy Professionals
- College Dropout Thrives in Real Estate Without Owning
- Exploring Promising Micro-Cap Stocks with Big Potential Gains
- Tractor Supply Plans Third Quarter Earnings Call Webcast
- Discover Luxury Living with Toll Brothers' New Community
- Chevrolet Silverado EV Work Truck: Affordable Electric Future
- Revised Wholesale Inventories Signal Economic Slowdown Ahead
- Venezuelan Bondholders Challenge Citgo Auction Amid Legal Turmoil
- Morgan Stanley Upgrades Alibaba: Price Target Increased Significantly
- Citi Adjusts Flat Glass Rating to Neutral Amid Profit Decline
- Sage Therapeutics Faces Challenges Amid Huntington's Potential
- Torex Gold Shows Promise with Record Production and Growth
- Shardbound Beta Launch: Exclusive Rewards Await Players
- ServiceNow and Zoom's AI Collaboration: A Game Changer
- Innovative AI Tool Launches for Enhanced Website Audits
- Jefferies Maintains Positive Outlook on Best Buy Shares in Retail Sector
- Restoration Robotics Faces 52-Week Low, Investors Remain Watchful
- Precision Optics Faces Market Challenges with New Strategies
- World Bank Predicts Shift in Economic Trajectory for 2024
- GSK Secures $2.2 Billion Settlement for Zantac Lawsuits
- Mexico's Cybercrime Challenges Amid Growing Nearshoring Trends
- Key Drivers Behind Carnival Corporation's Stock Performance
- An Important Call to Action for Ardelyx, Inc. Investors
- Class Action Lawsuit Notification for New Fortress Energy Inc.
- WEBTOON Entertainment Inc. Faces Legal Challenge Over Losses
- Investors Alert: Super Micro Computer, Inc. Class Action Lawsuit
- Terran Orbital Corporation Faces Class Action Lawsuit – Insights Within
- Rail Vision Ltd. Gains Momentum: Understanding the Recent Developments
- Shell's Strategic Share Buy-Back Program Explained
- Understanding the Surge in Wells Fargo Options Trading Now
- Insightful Examination of NIO's Options Trends and Activities
- Exploring the Bullish Trends for Moderna's Stock Opportunities
- REVOLT WORLD 2024: A Transformative Celebration of Culture
- Venterra Realty Celebrates Recognition for Community Impact
- Toll Brothers Introduces Luxurious Lakefront Community Soon
- Revolutionary Cat Bed Launches in the US – A Comfort Breakthrough
- Atlantic International Corp. Expands Growth Partnership in Food Sector
- Revolutionizing Real Estate: Casa Shares' iOS App Launch
- Empowering Wellness: ¡Vive Tu Vida! Get Up! Get Moving! Events
- Morguard Enhances Downtown Presence with Strategic Acquisition
- Innovative Solar Array Drive Technology for Space Missions
- AI Image Generation Market Expected to Surge Beyond $1 Billion
- Discover the New Luxury Community at Crystal Lake by Toll Brothers
- ServiceNow and Zoom Collaborate to Enhance Productivity with AI
- Transformational Growth: How Autodesk Stock Has Thrived
- U.S. Common Dividend Payments Surge Despite Slow Growth
- Inflection Revolutionizes Global Employee Education Standards
- Cencora's Stock Growth: A Solid Investment Story Over 5 Years
- Affirm's Stock Sees Upgrade, Impactful Apple Pay Integration Ahead